Skip to main content
    T

    TherapeuticsMD Inc (TXMD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $1.91
    +0.10 (+5.52%)

    Market Cap: $20.95M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    TherapeuticsMD Inc (TXMD) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    TherapeuticsMD (TXMD) has a latest price of $1.91 on Nov 17, 2026, 35.3% below its 52-week high of $2.95. Its price fell 2.6% over the past 12 months. The month-end price fell 99.4% over the 10 years through Oct 2026, a compound annual decline of 39.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $360.00 in Mar 2017 and its lowest $0.86 in Dec 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart TXMD with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TXMD.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 5.9%, and over 6 months it fell 6.4%. The month-end price fell 15.5% over the 3 years through Oct 2026, a compound annual decline of 5.5%.

    PeriodChange
    1 month+2.7%
    3 months-5.9%
    6 months-6.4%
    12 months-2.6%
    12 months, with dividends-2.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-15.5%-5.5%
    5 years-95.1%-45.2%
    10 years-99.4%-39.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 89.5%, and its weakest was 2021, when it fell 70.6%.

    YearCloseChange
    2026 through Oct 2026$1.80+10.4%
    2025$1.63+89.5%
    2024$0.86-61.8%
    2023$2.25-59.7%
    2022$5.59-68.6%
    2021$17.77-70.6%
    2020$60.50-50.0%
    2019$121.00-36.5%
    2018$190.50-36.9%
    2017$302.00+4.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.4% below its 50-day average of $1.96 and 8.2% below its 200-day average of $2.08.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.91
    52-week high$2.95-35.3%
    52-week low$1.43+33.6%
    50-day average$1.96-2.4%
    200-day average$2.08-8.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 75.6%.

    MeasureValue
    1-year beta0.28
    Largest fall, 1 year-39.0%
    Largest fall, 3 years-75.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About TXMD

    What is TXMD's 1-year price change?

    TherapeuticsMD's price fell 2.6% over the past 12 months. With dividends included, the 12-month total return was -2.6%.

    What is TXMD's 5-year price change?

    TherapeuticsMD's month-end price fell 95.1% over the 5 years through Oct 2026, a compound annual decline of 45.2%. These figures leave out dividends.

    What is TXMD's 52-week high and low?

    TherapeuticsMD's 52-week high is $2.95 and its 52-week low is $1.43. Its latest price of $1.91 on Nov 17, 2026 is 35.3% below the high.

    What is TXMD's beta?

    TherapeuticsMD's 1-year beta against the S&P 500 is 0.28, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 39.0%.

    Is the TXMD chart free?

    Yes. Advanced Charting for TXMD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.